Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Homoeopathic medicines: A detailed history and examination will be gathered from the already available information of the patient in the admission records at hospital. The patients rand
Sponsors
Central Council for Research in Homeopathy Ministry Ministry of Ayush
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age > 18 years 2. All sexes 3. Case definitions for inclusion in the study will include moderate and severe cases as defined in the Guidance on appropriate treatment of suspect/confirmed case of COVID19 issued by Ministry of Health and Family Welfare, Govt of India on 07 Apr 2020. a. Moderate: Pneumonia with no signs of severe disease (Respiratory Rate 15 to 30/minute, SpO2 90%-94%). b. Severe: Severe Pneumonia (with respiratory rate 4. Laboratory confirmed SARS CoV-2 infection within last 10 days or SARS 5. CoV-2 test result pending with a high clinical suspicion as defined by: a. Cough of b. Bilateral pulmonary infiltrates on chest X Ray / CT scan or new hypoxaemia defined as SpO2 c. No alternative explanation for respiratory symptoms d. Scheduled for admission or enrolled within 48h of hospital admission
Exclusion criteria
Exclusion criteria: 1. Children 2. Covid Positive patients with severe co-morbidities 3. Pregnant and lactating women, infants and neonates 4. Not willing to give consent for adjuvant treatment 5. Inability to be contacted on D14 for clinical outcome assessment (unless died in hospital) 6. In the opinion of the clinical team, progression to death is imminent and inevitable within the next 24 hours, irrespective of the provision of treatments. 7. Symptoms of acute respiratory tract infection for > 10d before randomisation, and covid status unknown 8. Death within 24 Hrs. of admission
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare duration required for change in disease status (from COVID positive to negative) in patients receiving adjuvant homoeopathic intervention with those receiving conventional treatment as institutional management protocol (IMP) in COVID-19 patients, categorized into moderate to severe stage of the diseaseTimepoint: To compare duration required for change in disease status (from COVID positive to negative) in patients receiving adjuvant homoeopathic intervention with those receiving conventional treatment as institutional management protocol (IMP) in COVID-19 patients, categorized into moderate to severe stage of the disease | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess overall symptomatic relief to patients through MYMOP2 scaleTimepoint: 3 Months | — |
Countries
India
Contacts
Public ContactDr Sushma Bhatnagar
All India Institute of Medical Sciences (AIIMS)
Outcome results
None listed